Please ensure Javascript is enabled for purposes of website accessibility

Analysts Sharply Raise Price Targets for Teladoc Health Stock

By Eric Volkman - Feb 28, 2020 at 9:22AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company's fourth-quarter results well exceeded what that pundits were expecting.

Teladoc Health (TDOC 0.78%) was quite the outlier stock on Thursday, rising sharply in price in the face of a severe downturn in the broader equities market. The company's excellent fourth-quarter results were the direct reason, and it was rewarded with a clutch of price target raises from analysts. 

Only a few hours after the results were released, a number of prognosticators lifted their targets, some quite dramatically for the telemedical-consultation specialist. One was Piper Sandler, whose analyst Sean Wieland increased his by 63% to $142 per share. In his update on the stock, Wieland wrote that Teladoc is experiencing a happy combination of falling visit acquisition costs and rising patient take-up.

Cowen, with its 50% hike, put a higher price tag on the shares of $150 apiece. SunTrust was more cautious, increasing its target, from $92 to $110. Analyst Alexander Draper at SunTrust, however, kept its hold recommendation on the shares intact. That contrasts with both Piper Sandler and Cowen; both companies still believe Teladoc is the equivalent of a buy.

Sick man making a phone call.

Image source: Getty Images

Teladoc's Q4 and full 2019 results were extremely encouraging. In the quarter, the company boosted its revenue by 27% on a year-over-year basis to almost $157 million, on the back of a 44% increase in total patient visits. The company's net loss narrowed to $19 million for the quarter, from a deficit of nearly $25 million a year earlier. Both headline numbers outperformed analysts' consensus estimates.

Teladoc was a rare bright light within Thursday's awful stock market action: The healthcare company rose by almost 16%, while the S&P 500 slid by 4.4%, its worst single-day showing since 2011.


Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Teladoc Health, Inc. Stock Quote
Teladoc Health, Inc.
$37.46 (0.78%) $0.29

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.